SUBSCRIBE
SUBSCRIBE
Genetown

Dyax Corp. to Participate in March 2011 Healthcare Conferences

March 1, 2011 | 
1 min read

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Dyax Corp. (NASDAQ: DYAX), a developer of novel biotherapeutics for unmet medical needs, announced today that executive management will participate in three upcoming conferences.

Events
MORE ON THIS TOPIC
Note paper with blood donation concept on red background
Sickle cell disease
Vertex, Beam Report SCD Cell and Gene Therapies Advances at ASH 2024
December 9, 2024
 · 
2 min read
 · 
Tristan Manalac
Businessman holding a dart aiming at the target - business targeting, aiming, focus concept. Art collage.
Bladder cancer
Protara, CG Oncology Tout Promising Bladder Cancer Outcomes
December 6, 2024
 · 
2 min read
 · 
Tristan Manalac
Businessman holding a dart aiming at the target - business targeting, aiming, focus concept. Art collage.
Cancer
AstraZeneca/Daiichi Sankyo, BioNTech, Merus to Present Promising Cancer Therapies at ESMO Asia 2024
December 2, 2024
 · 
4 min read
 · 
Tristan Manalac
Human liver protection. Wireframe low poly style. Concept for medical, pharmacology, treatment of the hepatitis. Abstract modern 3d vector illustration on dark blue background.
MASH
Novo, Viking Heat Up MASH Space with Promising Data at AASLD24
November 20, 2024
 · 
3 min read
 · 
Tristan Manalac